Former Massachusetts Sen. Paul Tsongas, who is currently apartner in the Boston law firm of Foley, Hoag & Eliot, waselected chairman of the board of directors of the non-profitWhitehead Institute for Biomedical Research, located inCambridge, Mass. The new vice chair of the Whitehead board isSusan Whitehead, daughter of the Institute's founder and wifeof Mitchel Sayare, chairman and chief executive officer ofImmunoGen Inc.
Albert Angel has joined the board of directors ofImmunomedics Inc. of Morris Plains, N.J. Angel is vicepresident, public affairs, of Merck & Co. Inc. and president ofthe Merck Company Foundation.
CytoTherapeutics Inc. of Providence, R.I., has appointedMarjorie Christie director of regulatory sciences. Christie joinsthe company from R.W. Johnson Pharmaceutical ResearchInstitute in Raritan, N.J., where she was director of biotechregulatory affairs.
CytoTherapeutics also appointed Donald Conklin, president ofSchering-Plough Pharmaceuticals and executive vice presidentof Schering-Plough Corp., to its board of directors.
Shareholders of Curative Technologies Inc. of East Setauket,N.Y., elected Lawrence Stuesser Jr. to the board of directors.Stuesser is chief executive officer of Kimberly Quality Care Inc.,a provider of home health-care services.
Michael Kurman has joined the clinical investigationsdepartment of Cytogen Corp. of Princeton, N.J., as director ofcancer therapeutics. Kurman had been the director of oncologyand allergy at Janssen Pharmaceutica USA.
Calgene Fresh Inc., a wholly owned subsidiary of Calgene Inc.,named Gary McKinsey director of field production. McKinseycame from Meyer Tomatoes, where he was the fieldsuperintendent for its California operations.
Michael Piraino has joined Syncor International Corp. ofChatsworth, Calif., as senior vice president of finance and chieffinancial officer. Previously, Piraino was senior vice presidentand chief financial officer of Total Pharmaceutical Care Inc.
Charles Ludlam, chief tax counsel for the Senate Small BusinessCommittee and a senior aide to Arkansas Sen. Dale Bumpers,has been named vice president for government affairs of theBiotechnology Industry Organization in Washington, D.C.Ludlam replaces Lisa Raines, who resigned recently to head thenew Washington office of Genzyme Corp.
Gliatech Inc. of Cleveland has appointed John Ufheil to its boardof directors and Michael Zupon as vice president of productdevelopment and operations. Zupon joined Gliatech fromSchering-Plough Corp., where he was the director of drugdelivery and technology assessment. Ufheil is chairman andchief executive officer of Celgene Corp.
Thomas O'Hara has joined Neocrin Co. as vice president offinance and administration and chief financial officer. O'Harajoined the Irvine, Calif., company from Vitarel MicroelectronicsInc., where he was vice president of finance/human resources,chief financial officer and treasurer.
PerSeptive Biosystems Inc. of Cambridge, Mass., has electedWilliam Pounds to its board of directors. Currently a professorof management at the Alfred P. Sloan School of Management atMIT, Pounds also served as dean of the Sloan School. He iscurrently a director of the Sun Company Inc., IdexxLaboratories Inc., Fisher Price Inc., The Putnam Funds andM/A-Com Inc.
PerSeptive Biosystems also appointed George Lenz vicepresident of research and development. Lenz had been thedirector of health-care research and development at The BOCGroup's Corporate Technical Center.
Vestar Inc. of San Dimas, Calif., appointed Anthony Cork,former vice president and general manager of Schering-PloughU.K. and Ireland, to the position of vice president, Europeancommercial operations. Cork will also take on the job of generalmanager of Vestar's subsidiaries in Ireland and the UnitedKingdom.
Stephen Appelbee has been named the European marketingmanager for Liposome Technology Inc., headquartered inMenlo Park, Calif. Appelbee, who will be based in London, hadbeen a marketing consultant and the international marketingdirector at Hovione International Ltd.
Altus Biologics Inc. of Cambridge, Mass., a subsidiary of VertexPharmaceuticals Inc., elected Daniel Wang to its scientificadvisory board. Wang directs the Biotechnology ProcessEngineering Center at MIT and is Chevron Professor of chemicalengineering at the school.
MicroCarb Inc. of Gaithersburg, Md., announced that RichardWalker has joined the company as director of vaccine research.Walker most recently was the science adviser to the nationalvaccine program of the Assistant Secretary for Health.
(c) 1997 American Health Consultants. All rights reserved.